Cannapharmarx, Inc. (CPMD): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2014-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$324.1K
Year ended 2014-12-31
Period endedR&D ExpenseChange YoYSource filing
2014-12-31$324.1Kn/a2015-03-31, From 2014-01-01